Humoral and cellular inflammatory mediators in acute lung injury: Friends or enemies?;Mediatori infiammatori umorali e cellulari dell'acute lung injury: Amici o nemici?

Minerva Medica

Volumn 94, Issue 3, 2003, Pages 157-165

  Buccelletti, F ^a   Mazzone, M ^a   Portale, G ^a   Forte, P ^a   Bononi, F ^a   Mirabella, C ^a   Travaglino, F ^a   Gentiloni Silveri, N ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Cytokines; Respiratory insufficiency, etiology; Respiratory insufficiency, immunology

Indexed keywords

COLLAGEN; FAS LIGAND; FIBRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ACUTE RESPIRATORY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; APOPTOSIS; CELL DAMAGE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; EXUDATE; HUMAN; HUMORAL IMMUNITY; HYPOXEMIA; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; LUNG COMPLIANCE; LUNG INFILTRATE; LUNG INJURY; MEDIATOR RELEASE; OXYGEN THERAPY; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; TACHYPNEA; THORAX RADIOGRAPHY;

ANTIBODY FORMATION; CYTOKINES; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION MEDIATORS; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 0142245896     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967;2:319-23.
2. Petty TL, Ashbaugh DG. The adults respiratory distress syndrome. Clinical features, factors influencing prognosis and principals of management. Chest 1971;60:233-9.
3. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988;138:720-3.
4. Abraham E, Matthay MA, Dinarello CA, Vincent JL, Cohen J, Opal SM et al. Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory di stress syndrome: time for a reevaluation. Crit Care Med 2000;28:232-5.
5. Artigas A, Bernard GR, Carlet J, Dreyfuss D, Gattinoni L, Hudson L et al. The American-European Consensus Conference on ARDS, part 2. Ventilatory, pharmacologic, supportive therapy, study design strategies and issues related to recovery and remodelling. Intensive Care Med 1998;24:378-98.
6. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L et al. The American European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcome and clinical trial coordination. Am J Respir Crit Care Med 1994;149(3 Pt 1):818-24.
7. Fowler AA, Hamman RF, Good JT, Benson KN, Baird M, Eberle DJ et al. Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med 1983;98 (5 Pt 1):593-7.
8. Pepe PE, Potkin RT, Reus DH, Hudson LD, Carrico CJ. Clinical predictors of the adult respiratory distress syndrome. Am J Surg 1982;144:124-30.
9. Moss M, Goodman PL, Heinig M, Barkin S, Ackerson L, Parsons PE. Establishing the relative accuracy of the three new definition of the adult respiratory distress syndrome. Crit Care Med 1995;23:1629-37.
10. Meade MO, Guyatt GH, Cook RJ, Groll R, Kachura JR, Wigg M et al. Agreement between alternative classifications of acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;163:490-3.
11. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in the sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-55.
12. Bone RC. Sir Isaac Newton, Sepsis, SIRS and CARS. Crit Care Med 1996;24:1125-8.
13. Bachofen M, Wiebel ER. Structural alteration of lung parenchymal in the adult respiratory distress syndrome. Clin Chest Med 1982;3:35-6.
14. Weiland JE, Davis WB, Holter JF, Mohammed JR, Dorinsky PM, Gadek JE. Lung neutrophils in the adult respiratory distress syndrome. Clinical and patophysiologic significance. Am Rev Respir Dis 1986;133:218-25.
15. Tomashefski JF jr. Pulmonary patholoay of the adult respiratory distress syndrome. Clin Chest Med 1990;11:593-619.
16. Matsubara O, Tamura A, Ohdama S, Mark EJ. Alveolar basement membrane breaks down in diffuse alveolar damage: an immunohistochemical study. Pathol Int 1995;45:473-82.
17. Anderson WR, Thielen K. Correlative study of adult respiratory distress syndrome by light scanding and transmission electron microscopy. Ultrastruct Pathol 1992;116:615-28.
18. Snyder LS, Hertz MI, Peterson MS, Harmon KR, Marinelli WA, Henke CA et al. Acute lung injury. Pathogenesis of intra-alveolar fibrosis. J Clin Invest 1991;88:663-73.
19. McHugh LG, Milberg JA, Whitcomb ME, Maunder RJ, Hudson LD. Recovery of function in survivors of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1994;150:90-4.
20. Chesnutt AN, Matthay MA, Tibayan FA, Clark JG. Early detection of type III procollagen peptide in acute lung injury. Pathogenic and prognostic significance. Am J Respir Crit Care Med 1997;156(3 Pt 1):840-5.
21. Marshall R, Bellingan GJ, Gunn S, Puddicome A, Goldsack N, McAnulty R et al. Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. Am J Respir Crit Care Med 2000;162:1783-8
22. Bellingan GJ, Marshall RP, Laurent GJ. Fibrosis in ARDS. How close is the link between inflammation and fibroproliferation? In: Vincent JL, editor. Yearbook of intensive care and emergency medicine. Berlin: Springer; 2000.p.217-24.
23. Bellingan GJ. The pulmonary physician in critical care * 6: The pathogenesis of ALI/ARDS. Thorax 2002;57:540-3.
24. Mortelliti MP, Manning HL. Acute respiratory distress syndrome. Am Fam Physician 2002;65:1823-30.
25. Luce JM. Corticosteroids in ARDS. An evidence-based review. Crit Care Clin 2002;18:79-89.
26. Vincent JL. New management strategies in ARDS. Immunomodulation. Crit Care Clin 2002;18:69-78.
27. Wong HR. ARDS. The future. Crit Care Clin 2002;18:177-96.
28. Gullo A. Spectrum of acute lung injury, ARDS, sepsis. Minerva Anestesiol. 2002;68:45-53.
29. Park WY, Goodman RD, Steinberg KP, Ruzinski JT, Radella F 2nd, Park DR et al. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;164(10 Pt 1):1896-903.
30. Heaney ML, Golde DW. Soluble receptors in human disease. J Leukoc Biol 1998;64:135-46.
31. Taga T, Hibi M, Hirata Y, Yamasaki K, Yasukawa K, Matsuda T et al. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 1989;58:573-81.
32. Donnelly SC, Strieter RM, Reid PT, Kunkel SL, Burkick MD, Armstrong I et al. The association between mortality rates and decreased concentration of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med 1996;125:191-6.
33. Tilg H, Dinarello CA, Mier JV. IL-6 and APPs: anti-inflammatory and immunosoppressive mediators. Immunol Today 1997;18:428-32.
34. Geiser T, Atabai K, Jarreau PH, Ware LB, Pugin J, Matthay MA. Pulmonary edema fluid from patient with acute lung injury augments in vitro alveolar epithelial repair by an IL-1-dependent mechanism. Am J Respir Crit Care Med 2001;163:1384-8.
35. Christman JW, Sadikot RT, Blackwell TS. The role of Nuclear Factor k-B in pulmonary disease. Chest 2000;117:1482-7.
36. Abraham E. NF-kB activation. Crit Care Med 2000;28 (Suppl.):N100-4.
37. Lentsch AB, Ward PA. Regulation of experimental lung inflammation. Respir Physiol 2001;128:17-22.
38. Schwartz MD, Moore EE, Moore FA, Shenkar R, Moine P, Haenel JB et al. Nuclear Factor kB is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med 1996;24(8):1285-92.
39. Held HD, Boettcher S, Hamann L, Uhlig S. Ventilation-induced chemokine and cytokine release is associated with activation of nuclear factor kB and is blocked by steroids. Am J Respir Crit Care Med 2001;163(3 Pt 1):711-6.
40. Meduri GU, Tolley EA, Chrousos GP, Stentz F et al. Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med 2002;165:983-91.
41. Kang JL, Lee HW, Lee HS, Pack IS, Chong Y, Castranova V et al. Genistein prevents nuclear factor kB activation and acute lung injury induced by lipopolysaccharide. Am J Respir Crit Care Med 2001;164:2206-12.
42. Walley KT, McDonald TE, Higashimoto Y, Hayashi S. Modulation of proinflammatory cytokines by nitric oxide in murine acute lung injury. Am J Respir Crit Care Med 1999;160:698-704.
43. Hashimoto S, Kobayashi A, Kooguchi K, Kitamura Y, Onodera H, Nakajima H. Upregulation of two death pathways of perforine/granzyme and FasL/Fas in septic acute respiratory distress syndrome. Am J Respir Crit Care Med 2000;161:237-43.
44. Kaufmann SH, Henganner MO. Programmed cell death: alive and well in the new millennium. Trends Cell Biol 2001;11:526-34.
45. Fine A, Anderson NL, Rothstein TL, Williams MC, Gochvico BR. Fas expression in pulmonary alveolar type II cells. Am J Physiol 1997;273(1 Pt 1):L64-71.
46. Matute-Bello G, Liles WC, Steinberg KP, Kiener PA, Mongovin S, Chi EY et al. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol 1999;163:2217-25.
47. Kitamura Y, Hashimoto S, Mizuta N, Kobayashi A, Kooguchi K, Fujiwara I et al. Fas/FasL-dependent apoptosis of alveolar cells after lipolysaccharide-induced lung injury in mice. Am J Respir Crit Care Med 2001;163:762-9.
48. Kawasaki M, Kuwano K, Hagimoto N, Matsuba T, Kunitake R, Tanaka T et al. Protection from lethal apoptosis in lipopolysaccharide-induced acute lung injury in mice by a caspase inhibitor. Am J Pathol 2002;157:597-603.
49. Matute-Bello G, Winn RK, Jonas M, Chi EY, Martin TR, Lile WC. Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: implications for acute pulmonary inflammation. Am J Pathol 2001;158:153-61.
50. Wang HC, Shun CT, Hsu SM, Kuo SH, Luh KT, Yang PC. Fas/Fas ligand pathway is involved in the resolution of type II pneumocyte hyperplasia after acute lung injury: evidence from a rat model. Crit Care Med 2002;30:1528-34.